HULC and metabolic dysfunction-associated steatotic liver disease: In addition, the inhibition of HULC can reduce hepatocyte apoptosis and ameliorate liver fibrosis to a certain extent in NAFLD rats, and therefore, it will serve as a potential therapeutic target for NAFLD [46].